Neogen (NEOG) Non-Current Deferred Tax Liability (2011 - 2026)

Neogen's (NEOG) quarterly Non-Current Deferred Tax Liability came in at $269.2 million in Q1 2026, down 10.58% year-on-year from $301.1 million in Q1 2025, and down 1.73% quarter-over-quarter from $273.9 million in Q4 2025.

Neogen (NEOG) Non-Current Deferred Tax Liability (2011 - 2026) Analysis & Trends

Neogen's Non-Current Deferred Tax Liability history runs 16 years deep, the most recent figure standing at $269.2 million for Q1 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 10.58% year-over-year to $269.2 million in Q1 2026; TTM through Feb 2026 was $269.2 million, a 10.58% decrease from a year earlier, with the FY2025 full-year figure at $280.9 million, down 14.02% from the prior year.
  • Non-Current Deferred Tax Liability declined to $269.2 million in Q1 2026 per NEOG's latest filing, from $273.9 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $364.3 million in Q4 2022 and bottomed at $15.9 million in Q3 2022.
  • The 5-year median for Non-Current Deferred Tax Liability is $302.4 million (2024), against an average of $267.5 million.
  • Across the five-year window, Non-Current Deferred Tax Liability declined 26.93% in 2022 and surged 2124.54% in 2023, its largest moves.
  • Year by year, Non-Current Deferred Tax Liability stood at $364.3 million in 2022, then declined by 2.54% to $355.0 million in 2023, then retreated by 14.82% to $302.4 million in 2024, then slipped by 9.41% to $273.9 million in 2025, then retreated by 1.73% to $269.2 million in 2026.
  • Per Business Quant, the three latest NEOG Non-Current Deferred Tax Liability figures stand at $269.2 million (Q1 2026), $273.9 million (Q4 2025), and $277.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 181.32 Bn 174.03 Bn 6.27 Bn
2 Stryker 128.59 Bn 125.71 Bn 3.81 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn
4 Boston Scientific 67.77 Bn 66.32 Bn 3.61 Bn
5 Edwards Lifesciences 48.13 Bn 44.46 Bn 1.29 Bn
6 GE HealthCare Technologies 28.44 Bn 26.15 Bn 1.98 Bn
7 Dexcom 28.41 Bn 27.29 Bn 750.30 Mn
8 Smith & Nephew 26.77 Bn 26.20 Bn -
9 Koninklijke Philips 25.24 Bn 22.11 Bn 2.07 Bn
10 Neogen 2.07 Bn 1.91 Bn 99.00 Mn

Historic Data

Download Data
DateValue
Feb 28, 2026 269.20 Mn
Feb 28, 2026 269.20 Mn
Nov 30, 2025 273.95 Mn
Nov 30, 2025 273.95 Mn
Aug 31, 2025 277.25 Mn
Aug 31, 2025 277.25 Mn
May 31, 2025 280.90 Mn
May 31, 2025 280.90 Mn
Feb 28, 2025 301.05 Mn
Feb 28, 2025 301.05 Mn
Nov 30, 2024 302.41 Mn
Nov 30, 2024 302.41 Mn
Aug 31, 2024 317.57 Mn
Aug 31, 2024 317.57 Mn
May 31, 2024 326.72 Mn
May 31, 2024 326.72 Mn
Feb 29, 2024 353.85 Mn
Feb 29, 2024 353.85 Mn
Nov 30, 2023 355.01 Mn
Nov 30, 2023 355.01 Mn